Rocket One Inc. Deferred Tax Assets, Capital Loss Carryforwards
Rocket One Inc. (RKTO) had Deferred Tax Assets, Capital Loss Carryforwards of $998.29 thousand as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-03-27
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $998.29K.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.04M.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $2.34M; Deferred Tax Assets, Capital Loss Carryforwards as first filed $2.27M.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $1.21M.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $998.29K 10-K · filed 2026-03-27 | |
| 2024-12-31 | $3.04M 10-K · filed 2026-03-27 | |
| 2023-12-31 | $2.34M 10-K · filed 2025-03-28 | $2.27M 10-K · filed 2024-03-28 |
| 2022-12-31 | $1.21M 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |